Search Results

You are looking at 61 - 70 of 1,090 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

HSR19-097: Understanding U.S. Mutational Testing Patterns and Treatment Implications in Gastrointestinal Stromal Tumors (GIST) Patients

Khalid Mamlouk, Zach Crouch, Philina Lee, Clive Mendonca, Maria Gumina, and Brian Rubin

treaters further examines mutational testing and treatment decisions to better understand current practices and educational needs. Methods: Hematologist/oncologists who practiced in academic or community settings were eligible if they treated ≥5 pts with

Full access

HSR23-117: First-Line (1L) Systemic Therapy in Patients (pts) With Advanced Non–Small Cell Lung Cancer (aNSCLC) at Community Settings in the United States (US)

Stephen Liu, Pragya Rai, Yu-Han Kao, Diana Chirovsky, and Ana Nunes

Full access

BPI24-024: Evaluating and Improving Post-Operative VTE Prophylaxis in Patients With a History of Cancer: Results of a Quality Improvement Initiative in a Community Hospital Setting

Caitlin Finelli, Kristen Conrad-Schnetz, and Tasha Bandiera

Full access

The Microbiome Colorectal Cancer Puzzle: Initiator, Propagator, and Avenue for Treatment and Research

Reece J. Knippel and Cynthia L. Sears

bacteria produce toxins, such as Bacteroides fragilis toxin and colibactin, that alter CEC signaling and/or damage CEC DNA, resulting in mutations and/or cytotoxicity that further alter host and microbial community function. (C) This multifactorial

Full access

SupportScreen: A Model for Improving Patient Outcomes

Matthew Loscalzo, Karen Clark, Jeff Dillehunt, Redmond Rinehart, Rex Strowbridge, and Daniel Smith

to be a time-consuming and daunting task for physicians when they have increasingly less time to spend with patients. This is true in both large academic cancer centers and small community practices. Several studies show the financial

Full access

HSR24-136: The Impact of Prescription Drug Plan (Part D) Enrollment for Medicare Beneficiaries on Eligibility for Episodic Value-Based Care Model Participation and Total Cost of Care (TCOC) at a Community Oncology Network

Jennifer Fernandez, John Albaugh, Lora Markley, Puneeth Indurlal, and Lalan Wilfong

Full access

BPI22-022: Real World Adherence to Biomarker Testing Guidelines That Inform First-Line Treatment Decisions for Patients Newly Diagnosed With Metastatic Non-Small Cell Lung Cancer in the Community Setting

Amy M. Pasmann, William E. Nibley, Scott D. Goldfarb, Veena Shetty, Jon M. Apple, and Anne Shah

Full access

Apoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trial

Stacy M. Fischer, Danielle M. Kline, Sung-Joon Min, Sonia Okuyama, and Regina M. Fink

the strategies we implemented to achieve our enrollment goals and engage an underrepresented population in a CCT. Methods Formative Work We developed our study methods and intervention content using community participatory action methods. We

Full access

HSR19-100: CancerSupportSource®-15: Development and Evaluation of a Short Form of a Distress Screening Program for Cancer Survivors

Shauna McManus, Alexandra K. Zaleta, Melissa F. Miller, Joanne S. Buzaglo, Julie S. Olson, Sara Goldberger, and Kevin Stein

Background: CancerSupportSource (CSS) is a 25-item distress screening tool implemented at community-based cancer support organizations and hospitals nationwide. CSS assesses distress over 5 domains: (1) emotional concerns (including depression and

Full access

Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer

Kelsey S. Lau-Min, Anne Marie McCarthy, Katherine L. Nathanson, and Susan M. Domchek

unstructured data, curated via technology-enabled abstraction. 13 The database included data from approximately 280 community and academic cancer clinics (∼800 sites of care) during the study period. Demographic variables for patients in the Flatiron Health